Praxis a new outperform at RBC on recent pullback
Source: SeekingAlpha
2026-06-18 10:31:22 ET
More on Praxis Precision Medicines
- Praxis Precision Medicines, Inc. (PRAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- Praxis' Premium Price May Reflect Unrealistic Market Prospects In Essential Tremor
- Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
- Praxis down on trial setback for seizure therapy
- Praxis Precision Medicines GAAP EPS of -$3.20
Read the full article on Seeking Alpha
For further details see:
Praxis a new outperform at RBC on recent pullback
Praxis Precision Medicines Inc.
NASDAQ: PRAX
PRAX Trading
-1.74% G/L:
$308.195 Last:
166,206 Volume:
$315 Open:
PRAX Latest News
July 07, 2026 08:00:00 am
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
$8,057,264,446
20,105,683
0.7%
83
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
